LACEY APPACHU: Open Payments
NPI 1124850649 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,803 in 70 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $761 · 2025 $1,803
Food & beverage: $1,803
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $268 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $188 |
| PROGENICS PHARMACEUTICALS, INC. | 7 | $180 |
| Ferring Pharmaceuticals Inc. | 8 | $155 |
| Janssen Biotech, Inc. | 8 | $141 |
| Blue Earth Diagnostics | 3 | $106 |
| Dendreon Pharmaceuticals LLC | 4 | $96 |
| UROGEN PHARMA, INC. | 4 | $95 |
| PFIZER INC. | 4 | $77 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $65 |
Products named: ORGOVYX, PYLARIFY, ADSTILADRIN, Xofigo, ERLEADA, Xtandi, POSLUMA, PROVENGE.
Industry payments across AZ — which companies pay providers there.
